Sedating child congenital heart disease my computer is not updating

28 May

It is safe at approved doses, but when much higher than recommended doses are taken, it can lead to serious problems, including severe heart rhythm problems and death.FDA is continuing to evaluate this safety issue and will update the public when more information is available.Customers that have any of the affected medications that are being recalled should immediately quarantine the product, discontinue use and destroy per their hospital protocol.Customers with any of the affected medications can also reference Phar MEDium Services website for more information on the specific lot numbers affected and contact information: Patients and healthcare providers with questions regarding this recall can contact Phar MEDium Services Clinical Pharmacist at (847) 457-2220, Monday through Friday, between 8am and 5pm Central Standard Time or via e-mail at [email protected] Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets(posted 11/16/2017)For Immediate Release PEAPACK, NJ, November 16, 2017 - Greenstone LLC, a wholly owned subsidiary of Pfizer Inc., is voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level.For some cases of abnormal heart rhythms in which drug treatment is ineffective, electrical pacing or cardioversion may be required.Also counsel patients to take loperamide only as prescribed or according to the OTC Drug Facts label and advise patients that drug interactions with commonly used medicines may increase the risk of serious cardiac events.

Phar MEDium Services is notifying customers of the voluntary recall by phone.Imodium (loperamide) for Over-the-Counter Use: Drug Safety Communication - FDA Limits Packaging To Encourage Safe Use(posted 1/30/2018)To foster safe use of the over-the counter (OTC) anti-diarrhea drug loperamide, FDA is working with manufacturers to use blister packs or other single dose packaging and to limit the number of doses in a package.FDA continues to receive reports of serious heart problems and deaths with much higher than the recommended doses of loperamide, primarily among people who are intentionally misusing or abusing the product, despite the addition of a warning to the medicine label and a previous communication. Loperamide acts on opioid receptors in the gut to slow the movement in the intestines and decrease the number of bowel movements.Compounded Sterile Products by Phar MEDium Services: Recall - Lack of Sterility Assurance(posted 1/2/2018)Phar MEDium Services is voluntarily recalling certain lots of drug products to the hospital/user level due to a lack of assurance of sterility.Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening.